Research Article

Jamb and Jamc Are Essential for Vertebrate Myocyte Fusion

  • Gareth T. Powell,

    Affiliation: Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom

  • Gavin J. Wright mail

    Affiliation: Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom

  • Published: December 13, 2011
  • DOI: 10.1371/journal.pbio.1001216


Cellular fusion is required in the development of several tissues, including skeletal muscle. In vertebrates, this process is poorly understood and lacks an in vivo-validated cell surface heterophilic receptor pair that is necessary for fusion. Identification of essential cell surface interactions between fusing cells is an important step in elucidating the molecular mechanism of cellular fusion. We show here that the zebrafish orthologues of JAM-B and JAM-C receptors are essential for fusion of myocyte precursors to form syncytial muscle fibres. Both jamb and jamc are dynamically co-expressed in developing muscles and encode receptors that physically interact. Heritable mutations in either gene prevent myocyte fusion in vivo, resulting in an overabundance of mononuclear, but otherwise overtly normal, functional fast-twitch muscle fibres. Transplantation experiments show that the Jamb and Jamc receptors must interact between neighbouring cells (in trans) for fusion to occur. We also show that jamc is ectopically expressed in prdm1a mutant slow muscle precursors, which inappropriately fuse with other myocytes, suggesting that control of myocyte fusion through regulation of jamc expression has important implications for the growth and patterning of muscles. Our discovery of a receptor-ligand pair critical for fusion in vivo has important implications for understanding the molecular mechanisms responsible for myocyte fusion and its regulation in vertebrate myogenesis.

Author Summary

The fusion of precursor cells is a crucial step in many biological processes, one of which is the development of skeletal muscle. The molecular and cell biology of fusion of muscle precursors has been well described in Drosophila melanogaster larvae, leading to insights into the process in vertebrates. However, the identity and mechanism of action of essential cell surface proteins for fusion between vertebrate muscle precursors has previously been lacking. Here, we describe a vertebrate-specific cell surface receptor pair that is essential for fusion in zebrafish: Jamb and Jamc. Loss of function of either receptor causes a near-complete block in fusion, resulting in an overabundance of mononucleate muscle fibres that are otherwise overtly normal. We demonstrate that Jamb and Jamc physically interact and are co-expressed by muscle precursors. Moreover, we show that the interaction between them is essential for fusion between neighbouring precursors in an embryo. We hypothesise that binding of Jamb to Jamc is a necessary recognition and adhesion step permissive for, but not sufficient to cause, myocyte fusion. Knowledge of these molecular components in vertebrates will lead to better understanding of how fusion is controlled to pattern skeletal muscle tissue.


Cell–cell fusion is crucial for several biological processes, including placental development [1], bone remodelling [2], fertilisation [3], and formation of skeletal muscle fibres [4], but surprisingly remains poorly understood. Skeletal muscle forms the bulk of tissue in vertebrates and is composed of bundles of long syncytial fibres formed by the fusion of post-mitotic muscle precursor cells (myocytes). It is a highly regenerative tissue, constantly undergoing repair and growth through the fusion of myocytes to form new fibres or supplement established ones. Impairment of the function of muscle, through age or genetic lesion, results in mild-to-severe pathologies that shorten lifespan, reduce quality of life, and demand a high burden of care. A more complete understanding of the molecular mechanisms of muscle development may lead to better treatment of muscle diseases and greater insights into regenerative medicine.

Muscle development has been well characterised in the larval body wall musculature of Drosophila melanogaster, where fusion occurs between two sub-populations of myoblasts, referred to as the fusion-competent myoblasts (FCMs) and founder cells [5][7]. The process of fusion has been resolved into a series of intermediate steps through ultrastructural analysis [8][10] and identification of the molecular components through forward genetics screens [11]. A critical step in fusion is the initial recognition and adhesion between the two cell types. This is regulated by the mutually exclusive expression of the cell surface receptor proteins Kirre and Sns, which form a heterophilic receptor pair between neighbouring cells [12][17]. Mutations in genes encoding these cellular recognition receptors (and their partially redundant paralogues Rst and Hbs) result in a severe block in fusion between the muscle precursors. In vertebrates, a functionally equivalent heterophilic receptor pair that is essential for myocyte fusion in vivo has yet to be identified [18]. One approach to isolate the vertebrate receptors has focussed on using sequence orthology to the fruitfly proteins—a rationale which is validated by emerging evidence that the molecular pathways important for myocyte fusion are conserved across these species [19][23]. Cell culture experiments have also suggested the involvement of several other cell surface proteins in vertebrate myocyte fusion, for example BOC and CDO [24]. Loss-of-function studies of these candidates resulted in mild disruption of myocyte fusion in vivo, leading to the view that this process involves several partially redundant proteins in vertebrates [18]. Only one vertebrate receptor, Kirrel3l (originally named Kirrel), has been identified as essential for myocyte fusion in vivo by using an antisense morpholino to knockdown the protein in zebrafish embryos [22]. There is no known Kirrel3l counter-receptor involved in the process of fusion, suggesting that other important vertebrate receptors remain to be discovered.

In this study, we identify two vertebrate cell surface receptors that are crucial for myocyte fusion: Jamb and Jamc (official nomenclature: Jam2a and Jam3b, respectively; Entrez gene: 100005261, 569217, respectively). The mammalian orthologues of both genes, commonly referred to as JAM-B and JAM-C (after rationalisation of the gene family nomenclature within the field [25]), have well-characterized roles in leukocyte migration [26], tight junction formation [27][29], and spermatogenesis [30]. Mouse Jam-B (Jam2) and Jam-C (Jam3) are members of a small sub-group of immunoglobulin superfamily cell surface proteins that is restricted to the deuterostome lineage (TreeFam [31]). They contain two extracellular immunoglobulin superfamily domains, a single transmembrane domain and a short cytoplasmic domain ending in a type II PDZ domain binding motif [32]. Heterophilic interactions between Jam-B and Jam-C are thought to be important for leukocyte transmigration across vascular endothelia [26] and the polarisation of spermatids necessary for complete differentiation into functional spermatozoa [30], but to date, there is no reported function for Jam-B and Jam-C in muscle development.

We have shown here that jamb and jamc are co-expressed in developing myoblasts and, by using mutant zebrafish, demonstrate that the physical interaction between them is essential for myocyte fusion in vivo. By analysing the mutant phenotypes and showing that jamc expression is misregulated in a muscle patterning mutant, we provide new insights into the regulatory mechanisms that govern vertebrate myogenesis.


Zebrafish jamb and jamc Are Co-Expressed by Fast Muscle Myoblasts

To identify novel receptor pairs that might be involved in myocyte fusion, we queried our large database of extracellular protein interactions constructed by screening a library of 249 zebrafish receptor proteins using the AVEXIS assay and supported by embryonic expression patterns of the corresponding genes during zebrafish embryonic development [33][35]. One pair, Jamb and Jamc, was selected because both genes are expressed by dividing myoblasts during primary myogenesis, but in distinct patterns. jamb is expressed by all fast muscle myoblasts shortly after the formation of each somite (Figure 1A). After approximately 10–13 somites have formed, jamc is initially highly expressed in a small, medial sub-population of fast muscle myoblasts along the dorsal-ventral axis (Figure 1B, 10–13 somites). Over time, the expression domain of jamc expands to include all myoblasts in the hypaxial and epaxial regions of the myotome (Figure 1B, 17–18 somites, 21 somites). jamb and jamc are co-expressed by all myoblasts in the anterior somites by the 17–18 somites stage (Figure 1, 17–18 somites) and in posterior somites at later stages (Figure 1, 21 somites). Whilst highly expressed in developing muscle, jamc also appears to be expressed at a basal level throughout the embryo—an observation that is replicated using a second riboprobe specific to the 3′ UTR of jamc (unpublished data). The expression of both genes in the myotome is attenuated in axial musculature by 24 h post-fertilisation (h. p. f.), but subsequently upregulated in later-developing craniofacial, abdominal, and pectoral fin muscles (Figure 1A,B). We conclude that both jamb and jamc are expressed in the somites of the embryo in a wave along the anterior-posterior axis. Within each somite, jamc expression begins medially and spreads laterally throughout the domain of jamb-expressing fast muscle myoblasts over time, so that both genes are co-expressed by myoblasts during the initial period of fusion between somitic precursors [20],[36]. Dynamic co-expression of the jamb and jamc genes in the developing musculature and later forming muscles suggested a role for the interaction between these two cell surface receptor proteins in myogenesis.


Figure 1. jamb and jamc are co-expressed in myoblasts.

(A–B) Wholemount in situ hybridisation of jamb (A) and jamc (B) show expression in myoblasts during somitogenesis (10–13 somites, 17–18 somites, and 21 somites). Expression is attenuated in the myotome after the completion of primary myogenesis (24 h. p. f.) and then later upregulated in craniofacial (cf), pectoral fin (arrows), and hypaxial (open arrowheads) muscle mesoderm (48 h. p. f.). Scale bars represent 50 µm.


jamb and jamc Are Essential for Myocyte Fusion

To establish whether jamb and jamc were important for myocyte fusion in vivo, mutant alleles of both genes were obtained from the Hubrecht Institute (HU3319) and Sanger Institute Zebrafish Mutation Resource (sa0037; Figure 2A). Mutations within selected exons of jamb and jamc were identified by amplifying and directly sequencing PCR products from libraries of chemically mutagenised zebrafish. The jambHU3319 allele is a nonsense mutation that results in a premature stop codon near the N-terminus of the protein. A truncating mutation was not recovered for the jamc gene, but one allele, jamcsa0037, contained a missense point mutation in a cysteine residue (C136 to Y) that is predicted to form a structurally critical disulphide bond. Both jambHU3319 and jamcsa0037 homozygous mutant embryos exhibited the same striking phenotype: regimented lines of centrally positioned nuclei within each myotome (Figure 2B). In wild-type embryos, somitic fast muscle myocytes fuse together to form multinucleate muscle fibres by approximately 24 h. p. f. [20],[36]. In jambHU3319 and jamcsa0037 mutants, fast muscle myocytes did not fuse, but instead, fully elongated to form mononuclear fibres that spanned each somite by 48 h. p. f. (Figure 2B) and remained mononucleate until at least 5 days post-fertilisation (Figure 2C). We quantified the lack of fusion in subsequent transplant experiments: 95% and 85% of fast fibres remained mononucleate in jambHU3319 donor into jambHU3319 host and jamcsa0037 donor into jamcsa0037 host transplants, respectively (Table 1). To provide independent evidence that the mutations in both jamb and jamc were responsible for the phenotype, we injected translation-blocking morpholino antisense oligonucleotides targeted to both jamb and jamc into wild-type embryos. Embryos injected with either morpholino phenocopied the mutants, demonstrating that the phenotype was not due to closely linked mutations in either the jambHU3319 or jamcsa0037 mutant lines (Figure 2D). From these experiments we conclude that zebrafish jamb and jamc are essential for myocyte fusion.


Figure 2. jamb and jamc are essential for myocyte fusion in vivo.

(A) Schematics of Jamb and Jamc extracellular proteins. Red stars denote sites of mutation in HU3319 and sa0037 alleles. (B–C) Confocal microscopy images of fast-twitch muscle in wild-type, jambHU3319, and jamcsa0037 48 h. p. f. (B) and 120 h. p. f. (C) Embryos labelled with membrane targeted RFP (mRFP, cyan; B) or phalloidin-Alexa488 (cyan; C) and DAPI (red) show overabundant, mononuclear myofibres in both mutants. (D) Confocal microscopy images of uninjected, jamb, and jamc translation-blocking morpholino-injected wild-type embryos, stained with DAPI (red) and phalloidin-Alexa488 (cyan) to stain F-actin in fast muscle fibres. The morpholino-injected embryos replicate the jam mutants' phenotype. Myotomes 12–13 shown, anterior left. Scale bars represent 50 µm.


Table 1. Quantification of fused (multinucleated) and unfused (mononucleated) fluorescently labelled fast muscle fibres in transplanted hosts.


Myogenesis Is Overtly Normal in Both jamb and jamc Mutants

In teleost fish, two spatially segregated muscle populations form during primary myogenesis: superficially located slow-twitch muscle and medial fast-twitch muscle [37][39]. Fast muscle fibres are syncytial (Figure 2B), but slow muscle fibres remain mononucleate during embryonic development [40]. To determine if the mononuclear muscle fibres in jambHU3319 and jamcsa0037 mutants do correctly differentiate as fast-twitch muscle, we used antibodies that are specific for the slow and fast isoforms of myosin heavy chain (sMyHC and fMyHC). We observed that both mutants had the same number of normal, superficially positioned slow muscle fibres (Figure 3A) with no ectopic expression of sMyHC within the deeper fibres. The medially located, and more numerous, mononuclear fibres in both mutants expressed fMyHC (Figure 3B), suggesting that specification of fast-twitch muscle was unaffected. Finally, we observed no difference in the ability and timing of spontaneous twitching and response to tactile stimuli in either mutant relative to wild-type, suggesting that the muscles were innervated and fully functional (unpublished data). Together, these data suggest that both mutants are able to complete the myogenic programme, except for a specific defect in fusion. These findings also suggest that other aspects of terminal differentiation, such as elongation and sarcomerogenesis, do not depend upon myocyte fusion in vertebrates.


Figure 3. Fast and slow-twitch muscle fibres are correctly specified in jambHU3319 and jamcsa0037 embryos.

(A) Superimposed confocal microscopy images of 24 h. p. f. wild-type, jambHU3319, and jamcsa0037 embryos stained with monoclonal antibody F59, which detects slow-muscle-specific myosin heavy chain (sMyHC), show normal slow muscle development in both mutants. (B) Single optical sections of 48 h. p. f. wild-type, jambHU3319, and jamcsa0037 embryos stained with monoclonal antibody EB165, which detects fast-muscle-specific myosin heavy chain (fMyHC), show that the medial mononuclear fibres in both mutants have differentiated as fast-twitch muscle. Myotomes 12–13 shown, anterior left. Scale bars represent 50 µm.


Fast Muscle Fibres Are Supernumerary in jamb and jamc Mutants

We observed an overt overabundance of fast muscle fibres in both mutants relative to wild-type embryos (Figure 2B). We quantified this increase by counting fibres outlined by a membrane-localised red fluorescent protein (mRFP) in optical cross-sections of wild-type and mutant embryos at 24, 32, and 48 h. p. f. (Figure 4A), revealing a statistically significant increase (p≤0.001) in fast fibre number in mutants by 1.6–1.8-fold, relative to wild-type (Figure 4B; Table S1). Interestingly, there was not as great an increase as might have been expected from the average number of nuclei in each wild-type fast muscle fibre (approximately 2.7 and 3.2 at 32 and 48 h. p. f., respectively; [20]). Staining mutant embryos with acridine orange did not reveal any increase in apoptosis relative to wild-type (unpublished data). In addition, we did not observe any rounded, unelongated, unfused myoblasts expressing fMyHC in either mutant or wild-type embryos (Figure 3B), suggesting that all somitic fast muscle myoblasts had undergone differentiation. Between 32 and 48 h. p. f., myotome muscle fibre number increased by a similar proportion in both mutant and wild-type embryos (Figure 4B). In contrast, the number of nuclei within each mutant myotome was decreased compared to wild-type embryos (Figure 4C; Table S2), suggesting that myoblast proliferation is limited in both mutants. In other words, growth of mutant, mononucleate fast muscle myotome requires less myocytes than the equivalent amount of growth of wild-type, syncytial fast muscle myotome. Taken together, these results reveal that the majority of fast muscle myoblasts could elongate and form functional mononuclear muscle fibres, resulting in an overabundance of fast muscle (Figure S1). This suggests that axial fast muscle precursors are not divided into distinct subpopulations.


Figure 4. Fast muscle fibres are supernumary in jambHU3319 and jamcsa0037 embryos.

(A) Transverse sections projected from confocal microscopy images of 48 h. p. f. embryos labelled with mRFP. (B–C) Graphs showing a significant overabundance (1.6–1.8-fold) of muscle fibres in mutants compared to wild-type (B) and calculated muscle nuclei number in wild-type and mutant embryos between 24 and 48 h. p. f. (C). Asterisk denotes p≤0.001; one-tailed Student's t test; error bars represent standard deviation, see Tables S1 and S2 for number of embryos in each sample.


Jamb and Jamc Physically Interact

Both jamb and jamc are expressed in fast muscle myoblasts during primary myogenesis (Figure 1) and loss-of-function of either gene results in a severe block in myocyte fusion (Figure 2), without overtly affecting any other aspect of axial muscle differentiation (Figure 3). Taken together, these results suggest that Jamb and Jamc are a receptor pair necessary for myocyte fusion.

The mammalian orthologues of Jamb and Jamc are known to form both homophilic [41],[42] and heterophilic [43] interaction pairs. Our large-scale systematic protein interaction screen identified a heterophilic interaction between zebrafish Jamb and Jamc, but no homophilic binding was observed [33]. Homophilic interactions are known to be the main class of false negatives in the AVEXIS assay used in these screens [33], so to determine whether zebrafish Jamb and Jamc could interact homophilically and to quantify the relative biophysical binding parameters, we used soluble recombinant proteins and surface plasmon resonance. We found that both Jamb and Jamc were able to bind each other with an equilibrium binding constant typical of extracellular protein interactions between membrane-embedded cell surface receptors (KD≈4.7±0.7 µM, Figure 5A; [44]). To compare between all three possible interactions of Jamb and Jamc, we used dissociation phase data of binding experiments to calculate dissociation rate constants (Figure 5B). We took this approach because equilibrium measurements can be confounded by unreliable estimates of analyte activities, which are affected by homophilic interactions within the analyte. Dissociation rate constants are independent of analyte activity and can therefore be more appropriately compared. As expected from studies of the mammalian orthologues, both proteins could also self-associate, but with a much weaker interaction strength than that of the heterophilic interaction (Figure 5B). All dissociation curves fitted a first-order decay equation well, suggesting a 1-to-1 binding mechanism. These experiments show that while zebrafish Jamb and Jamc are indeed able to form homodimers, the heterophilic interaction between them is significantly stronger.


Figure 5. Jamb and Jamc physically interact.

(A) Surface plasmon resonance experiments determine the equilibrium binding constant (KD) for the heterophilic interaction between Jamb and Jamc (inset: sensorgrams showing equilibrium has been reached). (B) Dissociation rate constants and half-lives of homophilic and heterophilic interactions between recombinant extracellular domains of Jamb and Jamc. Curves represent a fit to a first-order decay, indicating a 1:1 stoichiometry of binding. Dissociation data are the mean of three analyte concentrations for each interaction tested; error bars represent standard deviation.


The Interaction Between Jamb and Jamc Is Essential for Fusion In Vivo

Having established that both proteins could physically interact (Figure 5) and that jamb and jamc are co-expressed by myoblasts in wild-type (Figure 1) and mutant embryos (Figure S2), we used cellular transplantation experiments to determine the mechanism of binding between Jamb and Jamc for myocyte fusion in vivo.

Firstly, to demonstrate that jambHU3319 mutant myocytes are unable to fuse to each other, as observed in the mutant phenotype (Figure 2), we transplanted fluorescent dextran-labelled cells from jambHU3319 donors into jambHU3319 hosts and counted the number of labelled mononucleated or multinucleated fibres at 48 h. p. f. (Table 1). As expected, only 5% of myocytes derived from transplanted donor cells were able to fuse to mutant host myocytes, showing that expression of Jamc is unable to compensate for the loss of Jamb.

To establish if myocytes lacking jamb are nevertheless competent for fusion, we transplanted cells from jambHU3319 donors into wild-type hosts, and vice versa (Figure 6A and Table 1). When transplanted into wild-type hosts, 93% of jambHU3319 mutant cells could form multinucleate fibres, suggesting they are able to fuse with wild-type myocytes. Similarly, 95% of wild-type myocytes were able to form multinucleate fibres when transplanted into jambHU3319 hosts (Table 1). These results demonstrate that Jamb acts non-cell-autonomously, and that Jamb and Jamc need to be expressed by neighbouring cells for fusion to occur.


Figure 6. Interaction between jamb and jamc is necessary and required in trans for myocyte fusion.

(A–D) Fluorescent dextran-labelled cells (magenta) from jambHU3319 and jamcsa0037 donors can form multinucleate fibres with wild-type (A, B), jamcsa0037 (C), or jambHU3319 (D) host cells, respectively. (E, F) Transplanted cells from doubly-deficient donors fail to fuse with wild-type host cells, suggesting both proteins are required and interact in trans. Confocal microscopy images from 48 h. p. f. embryos; anterior left. Schematics illustrate potential binding of Jamb and Jamc between donor (magenta) and host (green) cells in each experiment. bMO, cMO indicate jamb or jamc translation-blocking morpholino-injected donor embryos. Dotted lines indicate the position of myotome boundaries; arrowheads indicate nuclei within labelled fibres. Nuclei stained with DAPI (green). Scale bars represent 20 µm.


To determine if the Jamb and Jamc interaction between cells is necessary for fusion, we tested the prediction that transplanted jambHU3319 mutant cells (that could nevertheless express wild-type Jamc) would be able to fuse to jamcsa0037 hosts (that could express wild-type Jamb). We observed that 96% of jambHU3319 mutant donor cells were able to fuse to jamcsa0037 mutant host cells (Figure 6C, Table 1). The cellular complementation between jamb and jamc mutant myocytes demonstrates that Jamb and Jamc must interact as a heterophilic pair on neighbouring cells and do not act as independent homophilic receptors.

To show that the interaction between Jamb and Jamc proteins was necessary for fusion and did not require any additional factors, donor cells that were deficient in both Jamb and Jamc (jambHU3319 embryos injected with a jamc-targeted morpholino) were transplanted into wild-type hosts (Figure 6E; Table 1). Most doubly-deficient donor cells (88%) could not fuse with wild-type host cells, demonstrating that expression of either Jamb or Jamc is essential for a myocyte to be competent for fusion. Doubly-deficient embryos are indistinguishable from jambHU3319 and jamcsa0037 mutant embryos, suggesting no further phenotypic enhancement from combined knockdown of both proteins (Figure S3).

We repeated each of the transplant experiments described above, except we used jamcsa0037 mutants as donors to establish if myocytes from both mutants behaved similarly. As with jambHU3319 transplants, we observed that jamcsa0037 donor cells were unable to fuse to jamcsa0037 host cells (Table 1), showing that Jamb is unable to rescue the loss of Jamc; Jamb and Jamc are not redundant. Wild-type donor cells were able to fuse to jamcsa0037 host cells and vice versa (Figure 6B, Table 1), demonstrating that jamc mutant myocytes are competent for fusion and suggesting that Jamb and Jamc need to be expressed by neighbouring cells for fusion to occur between them. In addition, jamcsa0037 donor cells were able to complement jambHU3319 host cells and fuse with wild-type efficiency (95%, Figure 6D, Table 1). This reinforces the conclusion that Jamb and Jamc must interact as a heterophilic pair between adjacent cells for fusion to occur. Finally, doubly deficient cells (jamcsa0037 embryos injected with a jamb-targeted morpholino; Figure S3) were unable to fuse to wild-type host myocytes (Figure 6F, Table 1), further demonstrating that no other factor is interacting with either Jamb or Jamc. Interestingly, jamcsa0037 mutant cells transplanted into a wild-type host fused less efficiently than into a jambHU3319 host, suggesting that homophilic Jamb interactions between donor and host myocytes could inhibit fusion in the absence of Jamc on the donor cell (compare jamcsa0037 donor, wild-type host and jamcsa0037 donor, jambHU3319 host; Table 1, Figure 6B and D). Taken together, these data show that the physical interaction between Jamb-Jamc is required between neighbouring cells for myocyte fusion to occur in vivo.

jamc Is Ectopically Expressed in prdm1a Mutant Slow Muscle Cells That Fuse Inappropriately

The overabundance of fast muscle fibres in the absence of myocyte fusion suggested that the regulation of jamb and jamc might play an important role in the control of muscle patterning and development.

Slow-twitch muscle myocytes do not undergo fusion during primary myogenesis [40]. However, in zebrafish embryos mutant for the transcriptional repressor prdm1a, the premigratory progenitors of slow-twitch muscle [39] express fast muscle-specific genes [45] and inappropriately fuse with the neighbouring fast muscle myocytes, resulting in the absence of slow muscle fibres [40]. These observations suggest that prdm1a mutant adaxial cells must ectopically express critical cell surface proteins necessary for myocyte fusion.

To test if either jamb, jamc, or kirrel3l [22] are ectopically expressed by prdm1a mutant adaxial cells, we performed wholemount in situ hybridization using riboprobes for each gene. We observed that jamc is misexpressed in the adaxial cells of prdm1atp39 embryos, but that jamb and kirrel3l are not (Figure 7). All three genes are expressed in fast muscle myoblasts of prdm1atp39 mutant embryos, as expected (Figure 7, Figure S4). These results suggest that misregulation of jamc permits ectopic fusion of mutant slow muscle precursors with neighbouring jamb-expressing fast muscle myocytes; in wild-type embryos, prdm1a represses jamc in adaxial cells to prevent this occurring. This also implies that a heterophilic interaction of Jamb and Jamc between mutant slow muscle cells and fast muscle myocytes is necessary for ectopic fusion events to occur. Finally, these data also suggest that transcriptional regulation of jamc triggers fast muscle myocyte fusion events in vertebrate musculature.


Figure 7. jamc expression is regulated by prdm1a.

Wholemount in situ hybridisation against jamc (left panels), jamb (middle panels), and kirrel3l (right panels) shows that jamc is ectopically expressed in premigratory slow muscle precursors (adaxial cells) of prdm1atp39 mutants that later inappropriately fuse to fast muscle myocytes. In contrast, jamb and kirrel3l are expressed in fast muscle myoblasts in both wild-type and prdm1atp39 mutant embryos. Flatmounted embryos at 10–13 somite stage; anterior top.


To determine if expression of jamc alone is sufficient to cause fusion events between slow muscle cells and fast muscle myocytes, we attempted to ectopically express jamc in wild-type slow muscle by microinjecting transgenic embryos containing a slow muscle marker, Tg(smyhc1::egfp)i104 [46], with full-length, capped jamc mRNA or a plasmid containing full-length jamc. We did not observe any ectopic fusion events with slow muscle cells in injected embryos (unpublished data), suggesting that other components, presumably also regulated by prdm1a, are necessary for fusion. Furthermore, we tested whether or not interaction between Jamb and Jamc is sufficient to drive fusion in heterologous cells, as described for the fusogen EFF-1 [47], by mixing HEK293E cells transfected with plasmids containing either full-length jamb or jamc. No fusion events were observed in mixed cultures of jamb- and jamc-transfected cells, or control cultures containing only jamb- or jamc-transfected cells (unpublished data). These results suggest that the context of Jamb and Jamc binding determines whether or not the interacting cells will fuse.


Using a combination of quantitative biochemistry, mutant zebrafish, and cell transplantation experiments, we have shown that we have identified a heterophilic interaction between a cell surface receptor pair that is essential in vivo for myocyte fusion in a vertebrate. This discovery has important implications for the molecular mechanism, regulation, and evolution of cellular fusion in the context of myogenesis.

The identification of Kirrel3l as a functional orthologue of Kirre/Rst in zebrafish and of other key intracellular effectors [19][23] suggests conservation of the important signalling pathways for the process of myocyte fusion between vertebrates and invertebrates. Our discovery of Jamb and Jamc as a new deuterostome-restricted [31] receptor pair that is essential for fusion in the zebrafish axial musculature raises the possibility of vertebrate-specific adaptations of the components and the regulation of muscle development in vertebrates. For example, our results suggest that this interaction is independent of Kirrel3l, suggesting that multiple recognition steps between vertebrate myocytes are required for fusion.

During differentiation, myocytes make a fundamental decision between founding a new muscle fibre or fusing to an existing one. In chicken and mouse embryos this decision seems to be temporally controlled: primary myocytes form an array of elongated mononucleate fibres, to which later differentiating myocytes fuse [48],[49]. In the larval body wall of Drosophila, this decision is controlled by early specification of myoblasts into two distinct subtypes, ultimately defining the number of muscle fibres formed [7],[12][16],[50]. Our results show that in the absence of fusion in the zebrafish axial musculature, the number of fast-twitch muscle fibres almost doubles, suggesting that the fast muscle precursors are not divided into defined subpopulations, but that each myocyte is capable of founding a fibre if it does not fuse to an existing one. The co-expression of these essential receptors in all fast muscle myoblasts adds to the suggestion that the precursors are not restricted to specific fates. In addition, our transplantation experiments did not reveal any functional subdivision of myocytes; approximately 95% of jamb or jamc mutant donor myocytes were able to undergo fusion with jamc or jamb host myocytes, respectively. The dynamic nature of jamc expression in fast muscle myoblasts and repression in slow muscle precursors suggest that regulation of jamc plays a fundamental role in the patterning of muscles through the timing of fusion events, rather than specification. Furthermore, other elements of terminal differentiation, such as elongation and sarcomerogenesis, seem to be independent of the process of fusion.

Our results suggest that the interaction between Jamb and Jamc expressed by neighbouring cells is essential for fusion. These cell surface receptors likely mediate an initial recognition and adhesion event similar to that of the cell surface receptors Kirre and Sns in Drosophila. It is unlikely that the interaction between Jamb and Jamc is sufficient for fusion because both proteins are known to be expressed and interact in other tissues that do not normally undergo fusion, such as the vascular endothelium [51]. Jamb and Jamc permit cellular recognition and adhesion, but do not cause fusion when expressed in heterologous cells such as CHO [52], MDCK [51], or HEK293E (unpublished data), unlike EFF-1, a known fusogen in C. elegans that causes spontaneous fusion between Sf9 insect cells transfected with membrane-bound splice variants [47]. In addition, ectopically expressing either Jamb or Jamc in zebrafish slow muscle cells did not result in inappropriate fusion with fast muscle precursors (unpublished data). We hypothesise that the biological context of Jamb and Jamc binding determines the productive output of that interaction; for example, cellular fusion or tight junction formation. Interaction between Kirre and Sns is thought to be the initiation event for the formation of a crucial adhesion and signalling complex between a founder cell and a fusion-competent myoblast, termed FuRMAS [9]. Both Kirre and Sns are thought to be involved in localising important signalling components to this complex, such as Rols7 and Mbc, in order to build and maintain a complex branched F-actin structure necessary for fusion [11]. Similarly, Jam-B and Jam-C are known to be involved in forming tight junctions between cells and localising other proteins such as ZO-1 to those sites [27][29]. A specialised fusion structure has not been reported or characterised in vertebrates to date, but Jamb and Jamc may form part of a similar complex that defines the site of fusion between myocytes.

A conserved role for JAM-B and JAM-C in myocyte fusion in other vertebrate organisms is an important focus for our future research. In support of this hypothesis, both genes have been shown to be expressed in developing skeletal muscle of mouse [53],[54] and human embryos [55]. Knockout mice models have been generated for both genes and studied in the context of fertility [30], immunity [56],[57], cardiac development [58], neurobiology [59], and stem cell biology [60]. Two independent Jam-C−/− models have been reported with high perinatal mortality [30],[57]; approximately two-thirds of mutant pups die within 48 h after birth and are described as cyanotic and gasping [57],[58]. The formation, structure, and integrity of the diaphragm has not been studied in these mice. Surviving Jam-C mutant mice also exhibit significant growth retardation starting from the second week of perinatal development [56],[58], megaeosophagus [56][58], weaker forepaw grip strength [59], and “jitteriness” [58]. These characteristics could conceivably be a result of underlying muscle defects. Mice deficient in Jam-B display no overt phenotype [53],[60] although skeletal muscle development and growth have not been specifically examined in detail.

We believe that identification of the critical function of jamb and jamc in zebrafish myocyte fusion presents us with an opportunity to better understand myogenesis in higher vertebrates and cellular fusion in other biological contexts. A molecular explanation of the intercellular recognition processes that are necessary for fusion in, for example, placenta formation and sperm-egg interactions remains incomplete. The identification of Jamb and Jamc as an in vivo validated receptor-ligand pair required for cellular fusion in vertebrates may now provide impetus to shed more light on these biological processes.

Materials and Methods

Zebrafish Husbandry, Embryo Culture, and Fixation

Zebrafish mutants carrying alleles jambHU3319 and jamcsa0037 were obtained from the Hubrecht laboratory and Wellcome Trust Sanger Institute Zebrafish Mutant Resource and maintained according to standard fish husbandry conditions and UK Home Office and Institute regulations and guidelines. Both jamb and jamc mutant lines were homozygous viable and fertile in our aquarium, but did not thrive. Embryos were fixed in either 4% paraformaldehyde or, for EB165 immunohistochemistry, in methanol.

Nomenclature and Accession Numbers

We refer to the zebrafish homologues of JAM-B and JAM-C as jamb and jamc, respectively, for the sake of clarity and consistency with other recent literature concerning the JAM family [26]. The official symbols and accession/reference numbers are as follows: jamb (official symbol jam2a) - Entrez gene: 100005261; jamc (official symbol jam3b) - Entrez Gene: 569217.

Protein Production, Purification, and Surface Plasmon Resonance

The extracellular domain of Jamb or Jamc were expressed as a soluble fusion protein with rat Cd4 domains 3 and 4 and either a 6-histidine (Cd4d3+4-6H) or an enzymatically biotinylatable peptide (Cd4d3+4-bio) C-terminal tag. These were purified and used in surface plasmon resonance experiments, essentially as previously described [33]. The activity of the Jamc analyte used in binding experiments cannot be accurately determined, as Jamc is capable of homophilic association. Dissociation rate constants (kd), which are not confounded by analyte activities (and can therefore be directly compared), were calculated by averaging the dissociation phase of three different concentrations of purified Jamc-Cd4d3+4-6H or Jamb-Cd4d3+4-6H protein and fitting a simple first-order decay curve. Fits to the data were good, suggesting a 1:1 stoichiometry of binding. Half lives (t½) were calculated by t½ = ln 2/kd.

Wholemount In Situ Hybridisation and Immunohistochemistry

Wholemount in situ hybridisations using digoxygenin-labelled riboprobes were performed using standard protocols [61]. Riboprobe templates were generated from plasmids containing the extracellular domain of jamb, jamc, or kirrel3l.

Wholemount immunohistochemistry was performed according to standard methods, using mouse monoclonal antibodies F59, EB165 (1:200; Developmental Studies Hybridoma Bank) and anti-mouse IgG, Alexa-488- or Alexa-568-conjugated secondary antibodies (1:5,000; Molecular Probes). Embryos were mounted in Slowfade Gold with DAPI (Molecular Probes) and/or treated with Alexa-488-conjugated phalloidin (1:40; Cambrex Biosciences).

Labelling Cell Membranes with mRFP

Capped membrane-targeted red fluorescent protein mRNA was transcribed from a linearised plasmid [62] using the mMessage mMachine kit (Ambion) and SP6 polymerase. 1–2 cell stage embryos were microinjected with approximately 4 nl of mRNA (~25 ng/µl) diluted in sterile water, 0.1% phenol red (Sigma-Aldrich), fixed with 4% paraformaldehyde, and observed by confocal microscopy. Optical cross-sections of fixed, 48 h. p. f. mRFP-labelled embryos were computed from z-stacks collected from myotomes 10–15 in each embryo, using Leica Application Suite Advanced Fluorescence software (LAS AF; Leica Microsystems). Fibres were manually counted in each cross-section; superficial slow muscle fibres were excluded from analysis. Estimation of nuclei was determined by mfhnh+(1−m)fh, where m is the fraction of multinucleated fibres (quantified in same donor into same host genotype transplant controls; Table S1), fh is the number of fibres, nh is the average number of nuclei per fibre reported [20], and h is the developmental stage in h. p. f.

Morpholino Treatment

1- and 2-cell stage embryos were injected with approximately 4 nl of translation blocking morpholinos (~200 µM, 5–7.5 ng per embryo) diluted in sterile water with 0.1% phenol red. Translation blocking morpholino sequences were as follows: jamb: GCA CAC CAG CAT TTT CTC CAC AGT G; jamc: TTA ACG CCA TCT TGG AGT CGG TGA A.

Cell Transplants

Transplants were performed essentially as described [63]. Briefly, 1–2-cell stage donor embryos were injected with lysine-fixable fluorescein or rhodamine labelled dextran (10,000 kDa, 1% in sterile water; Molecular Probes). Fluorescently labelled donor cells were transplanted into the marginal cells of unlabelled host embryos between high/sphere to ~30% epiboly stages. Transplanted embryos were maintained in embryo media supplemented with penicillin (50 U/ml) and streptomycin (50 µg/ml), fixed in 4% paraformaldehyde at 48 h. p. f., and analysed by confocal microscopy.

Image Acquisition and Processing

Confocal microscopy images were collected using a Leica SP5/DM6000 confocal microscope and LAS AF software. Wholemount in situ hybridisation images were obtained using a Zeiss Imager M1 microscope, Zeiss AxioCam Hrc camera, and Zeiss AxioVision software. Entire images were adjusted for contrast, brightness, dynamic range, and resampled to a standardised resolution (300 d. p. i.) using Adobe Photoshop CS2.

Statistical Analysis

Statistical significance between wild-type and mutant fibre counts and nuclei estimates were determined by one-tailed Student's t test, modified to take unequal sample size and variance into account. The number of embryos is presented in Table S1.

Supporting Information

Figure S1.

Model of fast muscle development in jam mutant and wild-type embryos. Each panel presents a schematic of a single somite (so), notochord (nc), and adaxial cell (ad) or migrating slow muscle fibres (sm) as viewed dorsally, anterior left, at different stages during somitogenesis; latest stage to the right. In wild-type embryos, fast-twitch myoblasts (fMBs) express jamb (blue). At approximately 10–13 somites stage, medio-posterior myoblasts begin to express jamc, in addition to jamb (red), and differentiate (upper left panel). Other myocytes are able to fuse to the jamb, jamc expressing myocytes once fully elongated (white arrows, upper middle panel) resulting in multinucleated muscle fibres (upper right panel; nuclei in dark red). This process continues medio-laterally, as slow muscle fibres (sm) migrate to a superficial position (yellow arrow), until all primary somitic fast-twitch myoblasts have fused together to form the fast muscle myotome. Future growth of the myotome requires proliferation of the external cell layer (yellow cells)—myoblasts that are initially within the anterior border of the early somite (ABCs, anterior border cells). In jam mutant embryos, jamb and jamc are expressed normally (lower left panel). In contrast to wild-type, jambHU3319 or jamcsa0037 myocytes are unable to undergo fusion (lower middle panel) and instead differentiate to form mononucleate fibres (lower right panel), nearly doubling the number of fast muscle fibres.



Figure S2.

Expression of jamb and jamc in jambHU3319 and jamcsa0037 mutant embryos. In situ hybridisation of jamb (left two panels) and jamc (right two panels) riboprobes to jambHU3319 and jamcsa0037 embryos at 17–18 somites stage; anterior top. Both genes are expressed in fast muscle myoblasts in both jambHU3319 and jamcsa0037 mutants as observed in wild-type embryos.



Figure S3.

Combined knockdown of jamb and jamc does not result in a synthetic myogenesis phenotype. (A, B) Antisense morpholino oligonucleotide knockdown of expression of jamc in jambHU3319 embryos (A, right) or jamb in jamcsa0037 embryos (B, right) does not result in any further disruption of myogenesis than that observed in jambHU3319 (A, left) or jamcsa0037 (B, left) at 48 h. p. f., suggesting no synthetic effect of combined knockdown of both genes. Single confocal microscopy images of myotomes 12–13 in 48 h. p. f. embryos, stained for F-actin (cyan) and nuclei (red). Anterior left; scale bars represent 50 µm.



Figure S4.

jamc expression in fast muscle myoblasts and adaxial cells of prdm1atp39 mutants. jamc is expressed in fast muscle myoblasts (open arrowheads) and ectopically expressed in premigratory slow muscle precursors (adaxial cells; closed arrowheads) of prdm1atp39 mutant embryos (bottom). Flatmounted wild-type sibling (top) and prdm1atp39 mutant embryos (bottom) at 18–20 somites stage, hybridised to jamc; anterior left.



Table S1.

Average number of fast muscle fibres per myotome in wild-type and mutant embryos at different developmental stages. Values presented as mean ± SD; n, number of embryos tested; n.a., not applicable as fibres have not elongated. Significantly different from wild-type, p≤0.001. Significantly different from jambHU3319, p≤0.01. One-tailed t test, modified to account for unequal sample sizes and sample variance.



Table S2.

Average number of nuclei per myotome, calculated from number of fast muscle fibres per myotome in wild-type and mutant embryos at different developmental stages, taking the fraction of multinucleated fibres into account (Table 1). Values presented as mean ± SD, number of embryos tested as in Table S1. *Values from (Moore et al., 2007) [20]. Significantly different from wild-type, p≤0.001. Significantly different from jambHU3319, p≤0.01. One-tailed t test, modified to account for unequal sample sizes and sample variance.




For providing the zebrafish knockout alleles HU3319 and sa0037, we thank the Hubrecht laboratory and the Wellcome Trust Sanger Institute Zebrafish Mutation Resource. We thank Mariella Ferrante for the mrfp construct, Stone Elworthy for prdm1atp39 embryos, Sudipto Roy for the kirrel3l cDNA, Simon Hughes for providing Tg(smyhc1:egfp)i104 embryos, Cécile Crosnier for assistance in generating injection constructs, and members of the laboratory and Michael Bate for critical comments on the manuscript.

Author Contributions

The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: GTP GJW. Performed the experiments: GTP GJW. Analyzed the data: GTP GJW. Contributed reagents/materials/analysis tools: GTP. Wrote the paper: GTP GJW.


  1. 1. Huppertz B, Borges M (2008) Placenta trophoblast fusion. Methods Mol Biol 475: 135–147.
  2. 2. Ishii M, Saeki Y (2008) Osteoclast cell fusion: mechanisms and molecules. Mod Rheumatol 18: 220–227.
  3. 3. Sutovsky P (2009) Sperm-egg adhesion and fusion in mammals. Expert Rev Mol Med 11: e11.
  4. 4. Capers C. R (1960) Multinucleation of skeletal muscle in vitro. J Biophys Biochem Cytol 7: 559–566.
  5. 5. Bate M (1990) The embryonic development of larval muscles in Drosophila. Development 110: 791–804.
  6. 6. Haralalka S, Abmayr S. M (2010) Myoblast fusion in Drosophila. Exp Cell Res 316: 3007–3013.
  7. 7. Rochlin K, Yu S, Roy S, Baylies M. K (2010) Myoblast fusion: when it takes more to make one. Dev Biol 341: 66–83.
  8. 8. Doberstein S. K, Fetter R. D, Mehta A. Y, Goodman C. S (1997) Genetic analysis of myoblast fusion: blown fuse is required for progression beyond the prefusion complex. J Cell Biol 136: 1249–1261.
  9. 9. Kesper D. A, Stute C, Buttgereit D, Kreiskother N, Vishnu S, et al. (2007) Myoblast fusion in Drosophila melanogaster is mediated through a fusion-restricted myogenic-adhesive structure (FuRMAS). Dev Dyn 236: 404–415.
  10. 10. Sens K. L, Zhang S, Jin P, Duan R, Zhang G, et al. (2010) An invasive podosome-like structure promotes fusion pore formation during myoblast fusion. J Cell Biol 191: 1013–1027.
  11. 11. Onel S. F, Renkawitz-Pohl R (2009) FuRMAS: triggering myoblast fusion in Drosophila. Dev Dyn 238: 1513–1525.
  12. 12. Bour B. A, Chakravarti M, West J. M, Abmayr S. M (2000) Drosophila SNS, a member of the immunoglobulin superfamily that is essential for myoblast fusion. Genes Dev 14: 1498–1511.
  13. 13. Artero R. D, Castanon I, Baylies M. K (2001) The immunoglobulin-like protein Hibris functions as a dose-dependent regulator of myoblast fusion and is differentially controlled by Ras and Notch signaling. Development 128: 4251–4264.
  14. 14. Shelton C, Kocherlakota K. S, Zhuang S, Abmayr S. M (2009) The immunoglobulin superfamily member Hbs functions redundantly with Sns in interactions between founder and fusion-competent myoblasts. Development 136: 1159–1168.
  15. 15. Ruiz-Gomez M, Coutts N, Price A, Taylor M. V, Bate M (2000) Drosophila dumbfounded: a myoblast attractant essential for fusion. Cell 102: 189–198.
  16. 16. Strünkelnberg M, Bonengel B, Moda L. M, Hertenstein A, de Couet H. G, et al. (2001) rst and its paralogue kirre act redundantly during embryonic muscle development in Drosophila. Development 128: 4229–4239.
  17. 17. Galletta B. J, Chakravarti M, Banerjee R, Abmayr S. M (2004) SNS: adhesive properties, localization requirements and ectodomain dependence in S2 cells and embryonic myoblasts. Mech Dev 121: 1455–1468.
  18. 18. Krauss R. S (2010) Regulation of promyogenic signal transduction by cell-cell contact and adhesion. Exp Cell Res 316: 3042–3049.
  19. 19. Laurin M, Fradet N, Blangy A, Hall A, Vuori K, et al. (2008) The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo. Proc Natl Acad Sci U S A 105: 15446–15451.
  20. 20. Moore C. A, Parkin C. A, Bidet Y, Ingham P. W (2007) A role for the myoblast city homologues Dock1 and Dock5 and the adaptor proteins Crk and Crk-like in zebrafish myoblast fusion. Development 134: 3145–3153.
  21. 21. Sohn R. L, Huang P, Kawahara G, Mitchell M, Guyon J, et al. (2009) A role for nephrin, a renal protein, in vertebrate skeletal muscle cell fusion. Proc Natl Acad Sci U S A 106: 9274–9279.
  22. 22. Srinivas B. P, Woo J, Leong W. Y, Roy S (2007) A conserved molecular pathway mediates myoblast fusion in insects and vertebrates. Nature Genet 39: 781–786.
  23. 23. Vasyutina E, Martarelli B, Brakebusch C, Wende H, Birchmeier C (2009) The small G-proteins Rac1 and Cdc42 are essential for myoblast fusion in the mouse. Proc Natl Acad Sci U S A 106: 8935–8940.
  24. 24. Kang J. S, Mulieri P. J, Hu Y, Taliana L, Krauss R. S (2002) BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation. EMBO J 21: 114–124.
  25. 25. Muller W. A (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24: 327–334.
  26. 26. Weber C, Fraemohs L, Dejana E (2007) The role of junctional adhesion molecules in vascular inflammation. Nature Rev Immunol 7: 467–477.
  27. 27. Aurrand-Lions M, Duncan L, Ballestrem C, Imhof B. A (2001) JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem 276: 2733–2741.
  28. 28. Mandicourt G, Iden S, Ebnet K, Aurrand-Lions M, Imhof B. A (2007) JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration. J Biol Chem 282: 1830–1837.
  29. 29. Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer F, Butz S, et al. (2003) The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J Cell Sci 116: 3879–3891.
  30. 30. Gliki G, Ebnet K, Aurrand-Lions M, Imhof B. A, Adams R. H (2004) Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C. Nature 431: 320–324.
  31. 31. Ruan J, Li H, Chen Z, Coghlan A, Coin L. J. M, et al. (2008) TreeFam: 2008 update. Nucleic Acids Res 36: D735–D740.
  32. 32. Ebnet K, Suzuki A, Ohno S, Vestweber D (2004) Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci 117: 19–29.
  33. 33. Bushell K. M, Sollner C, Schuster-Boeckler B, Bateman A, Wright G. J (2008) Large-scale screening for novel low-affinity extracellular protein interactions. Genome Res 18: 622–630.
  34. 34. Söllner C, Wright G (2009) A cell surface interaction network of neural leucine-rich repeat receptors. Genome Biol 10: R99.
  35. 35. Martin S, Söllner C, Charoensawan V, Adryan B, Thisse B, et al. (2010) Construction of a large extracellular protein interaction network and its resolution by spatiotemporal expression profiling. Mol Cell Proteomics 9: 2654–2665.
  36. 36. Snow C. J, Goody M, Kelly M. W, Oster E. C, Jones R, et al. (2008) Time-lapse analysis and mathematical characterization elucidate novel mechanisms underlying muscle morphogenesis. PLoS Genet 4: e1000219. doi:10.1371/journal.pgen.1000219.
  37. 37. Currie P. D, Ingham P. W (1998) The generation and interpretation of positional information within the vertebrate myotome. Mech Dev 73: 3–21.
  38. 38. Ingham P. W, Kim H. R (2005) Hedgehog signalling and the specification of muscle cell identity in the zebrafish embryo. Exp Cell Res 306: 336–342.
  39. 39. Devoto S. H, Melancon E, Eisen J. S, Westerfield M (1996) Identification of separate slow and fast muscle precursor cells in vivo, prior to somite formation. Development 122: 3371–3380.
  40. 40. Roy S, Wolff C, Ingham P. W (2001) The u-boot mutation identifies a Hedgehog-regulated myogenic switch for fiber-type diversification in the zebrafish embryo. Genes Dev 15: 1563–1576.
  41. 41. Cunningham S. A, Arrate M. P, Rodriguez J. M, Bjercke R. J, Vanderslice P, et al. (2000) A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J Biol Chem 275: 34750–34756.
  42. 42. Santoso S, Orlova V. V, Song K, Sachs U. J, Andrei-Selmer C. L, et al. (2005) The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J Biol Chem 280: 36326–36333.
  43. 43. Arrate M. P, Rodriguez J. M, Tran T. M, Brock T. A, Cunningham S. A (2001) Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem 276: 45826–45832.
  44. 44. Wright G. J (2009) Signal initiation in biological systems: the properties and detection of transient extracellular protein interactions. Mol Biosyst 5: 1405–1412.
  45. 45. von Hofsten J, Elworthy S, Gilchrist M. J, Smith J. C, Wardle F. C, et al. (2008) Prdm1- and Sox6-mediated transcriptional repression specifies muscle fibre type in the zebrafish embryo. EMBO Rep 9: 683–689.
  46. 46. Elworthy S, Hargrave M, Knight R, Mebus K, Ingham P. W (2008) Expression of multiple slow myosin heavy chain genes reveals a diversity of zebrafish slow twitch muscle fibres with differing requirements for Hedgehog and Prdm1 activity. Development 135: 2115–2126.
  47. 47. Podbilewicz B, Leikina E, Sapir A, Valansi C, Suissa M, et al. (2006) The C. elegans developmental fusogen EFF-1 mediates homotypic fusion in heterologous cells and in vivo. Dev Cell 11: 471–481.
  48. 48. Gros J, Scaal M, Marcelle C (2004) A two-step mechanism for myotome formation in chick. Dev Cell 6: 875–882.
  49. 49. Venters S. J, Thorsteinsdottir S, Duxson M. J (1999) Early development of the myotome in the mouse. Dev Dyn 216: 219–232.
  50. 50. Rushton E, Drysdale R, Abmayr S. M, Michelson A. M, Bate M (1995) Mutations in a novel gene, myoblast city, provide evidence in support of the founder cell hypothesis for Drosophila muscle development. Development 121: 1979–1988.
  51. 51. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof B. A (2001) Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 98: 3699–3707.
  52. 52. Otto D. M, Campanero-Rhodes M. A, Karamanska R, Powell A. K, Bovin N, et al. (2011) An expression system for screening of proteins for glycan and protein interactions. Anal Biochem 411: 261–270.
  53. 53. Tang T, Li L, Tang J, Li Y, Lin W. Y, et al. (2010) A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 28: 749–755.
  54. 54. Visel A, Thaller C, Eichele G (2004) an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res 32: D552–D556.
  55. 55. Phillips H. M, Renforth G. L, Spalluto C, Hearn T, Curtis A. R, et al. (2002) Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis. Genomics 79: 475–478.
  56. 56. Imhof B. A, Zimmerli C, Gliki G, Ducrest-Gay D, Juillard P, et al. (2007) Pulmonary dysfunction and impaired granulocyte homeostasis result in poor survival of Jam-C-deficient mice. J Pathol 212: 198–208.
  57. 57. Praetor A, McBride J. M, Chiu H, Rangell L, Cabote L, et al. (2009) Genetic deletion of JAM-C reveals a role in myeloid progenitor generation. Blood 113: 1919–1928.
  58. 58. Ye M, Hamzeh R, Geddis A, Varki N, Perryman M. B, et al. (2009) Deletion of JAM-C, a candidate gene for heart defects in Jacobsen syndrome, results in a normal cardiac phenotype in mice. Am J Med Genet A 149A: 1438–1443.
  59. 59. Scheiermann C, Meda P, Aurrand-Lions M, Madani R, Yiangou Y, et al. (2007) Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves. Science 318: 1472–1475.
  60. 60. Sakaguchi T, Nishimoto M, Miyagi S, Iwama A, Morita Y, et al. (2006) Putative “stemness” gene jam-B is not required for maintenance of stem cell state in embryonic, neural, or hematopoietic stem cells. Mol Cell Biol 26: 6557–6570.
  61. 61. Thisse C, Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nature Protoc 3: 59–69.
  62. 62. Ciruna B, Jenny A, Lee D, Mlodzik M, Schier A. F (2006) Planar cell polarity signalling couples cell division and morphogenesis during neurulation. Nature 439: 220–224.
  63. 63. Xu Q, Stemple D, Joubin K (2008) Microinjection and cell transplantation in zebrafish embryos. Methods Mol Biol 461: 513–520.